Biotech Blog

13 August 2007

Journal of Commercial Biotechnology

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.

The most recent issue, edited by Neil Henderson, has just been published:

Volume 13, Issue 3

When should you fire the founder?

William Bains

Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEs

Jennifer Frahm, David C Ireland and Damian Hine

A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape

Gareth Williams

Measuring performance of field-medical programmes: Medical science liaison metrics consensus

Jane Chin

The commercialisation of bioinformatics and the threat of open-source software

Joseph F Greco

Intellectual property issues in nanotechnology

Lars Genieser and Michael Gollin

Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?

Pedro Reinares Lara and Emma Gutierrez de Mesa

Changing hopes and concerns about gene therapy in Japan

Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng and Masakazu Inaba

Legal and Regulatory Update

ReedSmith

The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb. If purchasing a subscription, please use subscriber code NH0707G01.

2 Comments currently posted.

James says:

Friedman,
Well, congratulations and all the best. You’re a hardworking man…there’s no doubt about that.

Rate of Attrition » Blog Archive » Running on Empty… for This says:

[...] 2500+ word plus manuscript for journal publication (one of my manuscripts was just published in the Journal of Commercial Biotechnology). I wrote two poems recently (I shared one of them publicly here) - and I rarely write poetry. I [...]